Loading data
CYPHNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | 1.5 m USD |
| Research and development expense | 25.67 m USD | 57.21 m USD | 73.23 m USD | 44.97 m USD | 32.16 m USD |
| Operating profit | -41.07 m USD | -70.06 m USD | -87.04 m USD | -56.76 m USD | -41.43 m USD |
| Interest expense | — | — | — | 54 k USD | 41 k USD |
| Profit before tax | 10.08 m USD | -66.97 m USD | -81.41 m USD | -54.45 m USD | -40.61 m USD |
| Income tax expense | 5.26 m USD | 585 k USD | — | 147 k USD | -24 k USD |
| Net income (reported basis) | 5 m USD | -68 m USD | -81 m USD | -55 m USD | -40.59 m USD |
| Net income attributable to common shareholders | 4.82 m USD | -67.79 m USD | -81.41 m USD | -54.6 m USD | -40.59 m USD |
| Basic earnings per share | 0.07 USD/share | -1.81 USD/share | -3.98 USD/share | -4.82 USD/share | -0.47 USD/share |
| Diluted earnings per share | 0.07 USD/share | -1.81 USD/share | -3.98 USD/share | -4.82 USD/share | -0.47 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.